Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KI-MSC-PL-204 in Dysphonia and Vocal Fold Scarring
NCT04290182Phase 2Completed
- Sponsor
- Karolinska University Hospital
- Start
- Mar 2021
- Primary completion
- Jan 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MSC-KI-PL-204 in vocal fold scarring, dysphonia, Aphonia, sponsored by Karolinska University Hospital. Started Mar 2021; status: completed.
02
Drugs
MSC-KI-PL-204
03
Conditions
vocal fold scarringdysphoniaAphonia
Beyond the preview
Go deeper on NCT04290182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04290182.